- Home
- UPWK vs ARQT Comparison
UPWK vs ARQT Comparison
Compare UPWK & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPWK
- ARQT
- Stock Information
- Founded
- UPWK 2013
- ARQT 2016
- Country
- UPWK United States
- ARQT United States
- Employees
- UPWK N/A
- ARQT N/A
- Industry
- UPWK EDP Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- UPWK Technology
- ARQT Health Care
- Exchange
- UPWK Nasdaq
- ARQT Nasdaq
- Market Cap
- UPWK 2.3B
- ARQT 2.0B
- IPO Year
- UPWK 2018
- ARQT 2020
- Fundamental
- Price
- UPWK $12.62
- ARQT $13.80
- Analyst Decision
- UPWK Buy
- ARQT Strong Buy
- Analyst Count
- UPWK 13
- ARQT 6
- Target Price
- UPWK $18.75
- ARQT $18.80
- AVG Volume (30 Days)
- UPWK 1.9M
- ARQT 2.6M
- Earning Date
- UPWK 05-05-2025
- ARQT 05-13-2025
- Dividend Yield
- UPWK N/A
- ARQT N/A
- EPS Growth
- UPWK 2286.76
- ARQT N/A
- EPS
- UPWK 1.52
- ARQT N/A
- Revenue
- UPWK $769,325,000.00
- ARQT $196,542,000.00
- Revenue This Year
- UPWK N/A
- ARQT $60.21
- Revenue Next Year
- UPWK $7.31
- ARQT $40.21
- P/E Ratio
- UPWK $8.32
- ARQT N/A
- Revenue Growth
- UPWK 11.64
- ARQT 229.74
- 52 Week Low
- UPWK $8.43
- ARQT $6.99
- 52 Week High
- UPWK $18.14
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- UPWK 44.48
- ARQT 46.44
- Support Level
- UPWK $12.44
- ARQT $12.51
- Resistance Level
- UPWK $13.25
- ARQT $13.67
- Average True Range (ATR)
- UPWK 0.73
- ARQT 1.43
- MACD
- UPWK 0.09
- ARQT -0.27
- Stochastic Oscillator
- UPWK 67.37
- ARQT 34.83
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.